World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
39743
World Ranking
11137
National Ranking
604

Overview

Richard Dodel is affiliated with the University of Duisburg-Essen in Germany and has contributed extensively to the field of medicine, with a specific focus on neurology. Their research portfolio includes 135 publications primarily within medicine, of which 53 are in neurology, followed by significant work in psychiatry and mental health, physiology, general health professions, and economics and econometrics.

The scientist's main research themes encompass Parkinson's disease mechanisms and treatments, dementia and cognitive impairment research, neurological disorders and treatments, and health systems including economic evaluations and quality of life assessments. Alzheimer's disease research and treatments also represent a notable part of their work, alongside studies involving Ginkgo biloba and cashew applications and broader health and medical studies.

Frequent publication venues for Richard Dodel's work include Alzheimer s & Dementia, Der Nervenarzt, DGNeurologie, InFo Neurologie + Psychiatrie, and Neurological Research and Practice.

Key recent papers authored or co-authored by Richard Dodel include:

  • Trial of Deferiprone in Parkinson's Disease, 2022, New England Journal of Medicine
  • The late stage of Parkinson's - results of a large multinational study on motor and non-motor complications, 2020, Parkinsonism & Related Disorders
  • The Prevalence and Determinants of Neuropsychiatric Symptoms in Late-Stage Parkinsonism, 2020, Movement Disorders Clinical Practice
  • Bupropion for the Treatment of Apathy in Alzheimer Disease, 2020, JAMA Network Open
  • Alpha-synuclein Immunization Strategies for Synucleinopathies in Clinical Studies: A Biological Perspective, 2022, Neurotherapeutics

Richard Dodel frequently collaborates with several prominent researchers, including Stefan Lorenzl, Per Odin, Daniela Berg, Wassilios G. Meissner, and Alexander Storch, with each co-authoring multiple publications alongside them.

Best Publications

  • Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

    Christopher G. Goetz;Barbara C. Tilley;Stephanie R. Shaftman;Glenn T. Stebbins

  • Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

    Günter U Höglinger;Gesine Respondek;Maria Stamelou;Carolin Kurz

  • Cost of disorders of the brain in Europe 2010

    Anders Gustavsson;Mikael Svensson;Frank Jacobi;Christer Allgulander

  • Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.

    Christopher G. Goetz;Stanley Fahn;Pablo Martinez-Martin;Werner Poewe

  • Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

    Kelly R. Bales;Tatyana Verina;Richard C. Dodel;Richard C. Dodel;Yansheng Du

  • Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.

    Yansheng Du;Zhizhong Ma;Suizhen Lin;Richard C. Dodel

  • Prevalence and incidence of Parkinson's disease in Europe.

    Sonja von Campenhausen;Bernhard Bornschein;Regina Wick;Kai Bötzel

  • Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.

    Kelly R. Bales;Tatyana Verina;David J. Cummins;Yansheng Du

  • The natural history of multiple system atrophy: a prospective European cohort study

    Gregor K Wenning;Felix Geser;Felix Geser;Florian Krismer;Klaus Seppi

  • Intravenous immunoglobulins containing antibodies against β-amyloid for the treatment of Alzheimer’s disease

    R C Dodel;Y Du;C Depboylu;H Hampel

  • Long-Term Outcome After Stroke Evaluating Health-Related Quality of Life Using Utility Measurements

    Caroline Haacke;Astrid Althaus;Annika Spottke;Uwe Siebert

  • Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.

    H. Hampel;S. J. Teipel;T. Fuchsberger;N. Andreasen

  • Cognitive impairment in 873 patients with idiopathic Parkinson's disease : Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD)

    Oliver Riedel;Jens Klotsche;Annika Spottke;Giinther Deuschl

  • Reduced levels of amyloid β-peptide antibody in Alzheimer disease

    Y. Du;R. Dodel;H. Hampel;K. Buerger

  • The future of Alzheimer's disease: the next 10 years.

    Harald Hampel;David Prvulovic;Stefan Teipel;Frank Jessen

  • Cost of epilepsy: a systematic review.

    Adam Strzelczyk;Jens Peter Reese;Richard Dodel;Hajo M Hamer

  • Activation mapping in essential tremor with functional magnetic resonance imaging.

    Stefan F. Bucher;Klaus C. Seelos;Richard C. Dodel;Maximilian Reiser

  • Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson’s disease

    Oliver Riedel;Jens Klotsche;Annika Spottke;Giinther Deuschl

  • Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument

    Elke Kalbe;Pasquale Calabrese;Nils Kohn;Rüdiger Hilker

  • Association of an interleukin 1α polymorphism with Alzheimer’s disease

    Yansheng Du;R. C. Dodel;B. J. Eastwood;K. R. Bales

Frequent Co-Authors

Wolfgang H. Oertel
Wolfgang H. Oertel Philipp University of Marburg
Uwe Siebert
Uwe Siebert UMIT Tirol - Private University for Health Sciences and Health Technology
Daniela Berg
Daniela Berg University Hospital Schleswig-Holstein
Harald Hampel
Harald Hampel Eisai (United States)
Martin R. Farlow
Martin R. Farlow Indiana University
Frank Jessen
Frank Jessen University of Cologne
Brit Mollenhauer
Brit Mollenhauer University of Göttingen
Günther Deuschl
Günther Deuschl Kiel University
Claudia Trenkwalder
Claudia Trenkwalder University of Göttingen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring a future in Medicine, there are several related online degrees and specialized career pathways to consider. Many online programs offer flexibility, affordability, and the ability to balance studies with other commitments—making them ideal for aspiring healthcare professionals.

For those interested in healthcare data and administration, there are accredited online rhit degree programs that cover health information management essentials. Alternatively, if coding and billing systems are more your style, consider enrolling in medical billing and coding online courses to prepare for vital support roles in the healthcare industry.

Nursing is another rewarding path, with a range of accessible online offerings. Aspiring nurse practitioners can explore high-quality, cheap np programs that allow you to advance your scope of practice. For those beginning their nursing education, cheapest online bsn programs provide an affordable route to earning a Bachelor of Science in Nursing and starting your clinical career.

These online pathways can offer not only financial savings but also greater accessibility, so you can build a healthcare career to suit your interests and lifestyle.

Best Scientists Citing Richard Dodel

Trending Scientists